Extended collaboration targeting cell therapies generates revenues of EUR 130,000 in 2023

In November 2022, AcouSort reported that the company had entered a collaboration with a global life science company active within the cell therapy field. The first part of the project is now successfully finalized, and the two companies have jointly decided to extend the collaboration with a second phase generating revenues of EUR 130 000 to AcouSort in 2023. Cell therapy is an area where AcouSort sees great potential for the company’s technology within sample preparation automation.

Read the full press release here

Läs hela pressmeddelandet här